Wellington Shields & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.14M | Sell |
76,295
-4,661
| -6% | -$124K | 0.55% | 45 |
|
|
2025
Q4 | $2.02M | Buy |
80,956
+1,965
| +2% | +$49.6K | 0.5% | 47 |
|
|
2025
Q3 | $2.01M | Buy |
78,991
+97
| +0.1% | +$2.39K | 0.52% | 43 |
|
|
2025
Q2 | $1.91M | Buy |
78,894
+3,900
| +5% | +$91K | 0.54% | 43 |
|
|
2025
Q1 | $1.9M | Sell |
74,994
-800
| -1% | -$20.9K | 0.59% | 40 |
|
|
2024
Q4 | $2.01M | Sell |
75,794
-2,608
| -3% | -$70.7K | 0.62% | 36 |
|
|
2024
Q3 | $2.27M | Buy |
78,402
+608
| +0.8% | +$17.7K | 0.69% | 27 |
|
|
2024
Q2 | $2.18M | Buy |
77,794
+3,707
| +5% | +$102K | 0.71% | 27 |
|
|
2024
Q1 | $2.06M | Buy |
74,087
+1,808
| +3% | +$50.2K | 0.69% | 29 |
|
|
2023
Q4 | $2.08M | Sell |
72,279
-1,125
| -2% | -$34K | 0.77% | 28 |
|
|
2023
Q3 | $2.43M | Buy |
73,404
+13,964
| +23% | +$494K | 0.61% | 23 |
|
|
2023
Q2 | $2.18M | Sell |
59,440
-13,157
| -18% | -$512K | 0.51% | 28 |
|
|
2023
Q1 | $2.96M | Buy |
72,597
+2,055
| +3% | +$88.8K | 0.66% | 15 |
|
|
2022
Q4 | $3.61M | Buy |
70,542
+396
| +0.6% | +$19K | 0.82% | 12 |
|
|
2022
Q3 | $3.07M | Buy |
70,146
+1,474
| +2% | +$71.6K | 1.34% | 15 |
|
|
2022
Q2 | $3.6M | Sell |
68,672
-16,274
| -19% | -$829K | 0.87% | 16 |
|
|
2022
Q1 | $4.4M | Buy |
84,946
+5,283
| +7% | +$274K | 1.45% | 13 |
|
|
2021
Q4 | $4.7M | Buy |
79,663
+2,423
| +3% | +$120K | 0.94% | 10 |
|
|
2021
Q3 | $3.32M | Buy |
77,240
+325
| +0.4% | +$14.4K | 1.16% | 18 |
|
|
2021
Q2 | $3.01M | Buy |
76,915
+553
| +0.7% | +$21.5K | 0.99% | 23 |
|
|
2021
Q1 | $2.77M | Buy |
76,362
+1,505
| +2% | +$53.4K | 0.99% | 25 |
|
|
2020
Q4 | $2.75M | Sell |
74,857
-4,948
| -6% | -$181K | 0.99% | 23 |
|
|
2020
Q3 | $2.78M | Buy |
79,805
+1,195
| +2% | +$41.9K | 1.17% | 21 |
|
|
2020
Q2 | $2.44M | Buy |
78,610
+145
| +0.2% | +$4.93K | 1.07% | 24 |
|
|
2020
Q1 | $2.43M | Buy |
78,465
+676
| +0.9% | +$23K | 1.34% | 18 |
|
|
2019
Q4 | $2.89M | Buy |
77,789
+57,976
| +293% | +$2.07M | 1.28% | 20 |
|
|
2019
Q3 | $675K | Sell |
19,813
-57,715
| -74% | -$2.1M | 1.04% | 35 |
|
|
2019
Q2 | $3.19M | Sell |
77,528
-218
| -0.3% | -$8.66K | 1.5% | 15 |
|
|
2019
Q1 | $3.13M | Sell |
77,746
-523
| -0.7% | -$20.9K | 1.6% | 14 |
|
|
2018
Q4 | $3.24M | Buy |
78,269
+19,806
| +34% | +$822K | 1.86% | 9 |
|
|
2018
Q3 | $2.44M | Buy |
58,463
+1,793
| +3% | +$69K | 1.32% | 19 |
|
|
2018
Q2 | $1.95M | Sell |
56,670
-91
| -0.2% | -$3.11K | 1.01% | 28 |
|
|
2018
Q1 | $1.91M | Buy |
56,761
+120
| +0.2% | +$4.13K | 1.03% | 28 |
|
|
2017
Q4 | $1.95M | Sell |
56,641
-3,736
| -6% | -$127K | 1.05% | 29 |
|
|
2017
Q3 | $2.04M | Buy |
60,377
+634
| +1% | +$20.4K | 0.68% | 26 |
|
|
2017
Q2 | $1.9M | Sell |
59,743
-204
| -0.3% | -$6.43K | 0.66% | 24 |
|
|
2017
Q1 | $1.95M | Sell |
59,947
-1,477
| -2% | -$46.6K | 0.59% | 25 |
|
|
2016
Q4 | $1.89M | Sell |
61,424
-423
| -0.7% | -$12.9K | 0.99% | 25 |
|
|
2016
Q3 | $1.99M | Buy |
61,847
+95
| +0.2% | +$3.18K | 1.01% | 22 |
|
|
2016
Q2 | $2.06M | Buy |
61,752
+622
| +1% | +$19.9K | 1.28% | 15 |
|
|
2016
Q1 | $1.72M | Buy |
61,130
+5,712
| +10% | +$163K | 1.15% | 18 |
|
|
2015
Q4 | $1.7M | Buy |
55,418
+8,230
| +17% | +$259K | 1.13% | 17 |
|
|
2015
Q3 | $1.41M | Hold |
47,188
| – | – | 1.06% | 18 |
|
|
2015
Q2 | $1.5M | Hold |
47,188
| – | – | 0.5% | 18 |
|
|
2015
Q1 | $1.56M | Hold |
47,188
| – | – | 0.92% | 19 |
|
|
2014
Q4 | $1.4M | Hold |
47,188
| – | – | 0.8% | 22 |
|
|
2014
Q3 | $1.32M | Buy |
47,188
+211
| +0.4% | +$5.92K | 0.83% | 19 |
|
|
2014
Q2 | $1.32M | Buy |
46,977
+633
| +1% | +$18K | 0.83% | 19 |
|
|
2014
Q1 | $1.41M | Sell |
46,344
-738
| -2% | -$22K | 0.89% | 20 |
|
|
2013
Q4 | $1.37M | Buy |
47,082
+263
| +0.6% | +$7.65K | 0.92% | 19 |
|
|
2013
Q3 | $1.28M | Buy |
46,819
+16,095
| +52% | +$438K | 1.01% | 18 |
|
|
2013
Q2 | $816 | Buy |
+30,724
| New | +$849K | 0.02% | 40 |
|
Other funds holding PFE
VCM
VPM
Wellington Shields & Co's PFE Position: Q1 2026 in Review
Wellington Shields & Co reduced its Pfizer (PFE) stake by 5.8% in Q1 2026, selling an estimated $124K and leaving 76,295 shares worth $2.14M. The position accounts for 0.55% of the portfolio, ranked #45.
Wellington Shields & Co first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.7M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Wellington Shields & Co held 76,295 shares of Pfizer worth $2.14M as of Q1 2026.
- Wellington Shields & Co sold 4,661 Pfizer shares in Q1 2026, an estimated $124K.
- Pfizer made up 0.55% of Wellington Shields & Co's portfolio in Q1 2026, its #45 holding.
- Wellington Shields & Co first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Wellington Shields & Co's Pfizer position peaked at $4.7M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Wellington Shields & Co's 13F filing for Q1 2026, filed 4 May 2026.